Spotlight on Ramipril in the Prevention of Cardiovascular Outcomes

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.3, Iss.2, 2003-01, pp. : 113-116

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ramipril: A Review of its Use in the Prevention of Cardiovascular Outcomes

By Warner G.T. Perry C.M.

Drugs, Vol. 62, Iss. 9, 2002-01 ,pp. : 1381-1405

Adis International

Access to resources Recommend Favorite

Ramipril: A Review of its Use in Preventing Cardiovascular Outcomes in High-Risk Patients

By Anderson Vanessa R. Perry Caroline M. Robinson Dean M.

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 6, 2006-01 ,pp. : 417-432

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Ramipril in Patients at High Risk for Cardiovascular Events: Economic Evaluation of the HOPE (Heart Outcomes Prevention Evaluation) Study for Germany from the Statutory Health Insurance Perspective

By Peter K. Schädlich

PharmacoEconomics, Vol. 22, Iss. 15, 2004-01 ,pp. : 955-973

Adis International

Access to resources Recommend Favorite

Ramipril: beneficial for regression and prevention of LVH

Inpharma, Vol. 1, Iss. 1318, 2001-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Ramipril for stroke prevention independent of BP

Inpharma, Vol. 1, Iss. 1331, 2002-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite